Skip to main content
    A

    argenx NV ADR (ARGX)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $950.95
    -9.09 (-0.95%)

    Market Cap: $60.37B

    Last updated: Nov 17, 2026 at 5:31 PM ET

    argenx NV ADR (ARGX) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    argenx NV ADR (ARGX) has a market cap of $60.37B. Its trailing P/E is 33.2x.

    Total Valuation

    Market Cap$60.37B
    Latest price (Nov 17, 2026)$950.95

    Key Dates

    Last Earnings DateOct 22, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 0.74% in the quarter ended Sep 30, 2026 and grew 3.73% a year over 3 years.

    Shares Outstanding64.89M
    Shares Change (QoQ)+0.74%
    Share Count Growth (3Y CAGR)+3.73%

    Valuation Ratios

    Sales and book value multiples are 6.0x and 176.8x.

    P/E Ratio33.2x
    Forward P/E32.6x
    P/S Ratio6.0x
    P/B Ratio176.8x
    P/FCF Ratio32.7x
    PEG Ratio1.2

    Valuation history and multiples

    Price Statistics

    The stock is up 6.64% over 52 weeks and trades 3.11% above its 50-day average.

    Beta (1Y)0.54
    52-Week Change+6.64%
    1-Month Change+16.09%
    3-Month Change-4.23%
    6-Month Change+22.50%
    5-Year Change+195.69%
    Total Return (1Y)+6.64%
    Total Return (3Y CAGR)+24.77%
    Total Return (5Y CAGR)+26.73%
    Return vs SPY (1Y)-8.03%
    Max Drawdown (1Y)-28.58%
    Max Drawdown (3Y)-31.64%
    Sharpe Ratio (1Y)0.09
    Correlation with SPY (1Y)0.20
    50-Day Average$922.24
    200-Day Average$860.83
    52-Week Range$661.85 to $1,072.75
    RSI (14 Days)56.6
    Average Volume (20 Days)407.48K

    The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Total debt is 0.00x shareholder equity.

    Debt / Equity0.00x
    Interest Coverage567.24x

    Returns and Efficiency

    ROIC (5Y Average)-5.78%
    Inventory Turnover4.84x
    Receivables Turnover9.23x
    Cash Conversion Cycle-31 days

    Scores

    ARGX has a Piotroski F-Score of 4 of 9, in the average band of 3 to 7.

    Piotroski F-Score4 of 9
    Piotroski StrengthAverage

    Dividends and Yields

    ARGX does not pay a dividend. Its free cash flow yield is 3.06%.

    Earnings Yield3.01%
    FCF Yield3.06%

    Peer Position

    Against 6 similar companies, ARGX has the 3rd highest P/E.

    P/E Ratio33.2x vs 24.8x median
    P/S Ratio6.0x vs 17.5x median

    Competitors compared

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    GNG Valuation

    GNG viewUndervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About ARGX

    What is ARGX's market cap?

    argenx NV ADR has a market cap of $60.37B.

    What is ARGX's P/E ratio?

    argenx NV ADR has a trailing P/E ratio of 33.2x and a forward P/E of 32.6x.

    How many shares of ARGX are outstanding?

    argenx NV ADR has 64.89M shares outstanding.

    Does ARGX pay a dividend?

    No. argenx NV ADR does not pay a dividend.